• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal & Metabolism
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality
      • Environment, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
A portrait of Mary-Ann Browne who is surviving with heart failure
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/Patient Perspectives

Surviving with heart failure

Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's been a lack of progress in finding more effective medications. Advances in understanding mean new options for patients and caregivers. 

Jul 07, 2015

Retired registered nurse Mary-Ann Browne knows she has to live extremely carefully. With just one third of her heart muscle functioning properly, the Canadian is one of the more than a million people diagnosed with heart failure around the world every year. 

The outlook for patients with heart failure has been dismal. About 25% of patients die within a year of diagnosis and 50% are dead within five years and it is the biggest cause of hospital admissions in adults aged over 65 in the Western world. While existing treatments address symptoms such as fluid retention and breathlessness, advances in the understanding of heart failure mean new options for patients and caregivers. 

Heart failure is one of the most difficult of the chronic heart diseases to manage.

Michele Packard-Milam, Executive Director, Mended Hearts

Heart failure, a chronic condition in which the heart cannot pump enough blood around the body, has many causes but typically occurs because the heart muscle has weakened or been injured, such as following a heart attack, viral infection or other serious illness. Aging populations and changing lifestyles mean heart failure is now the most rapidly growing cardiovascular condition, affecting approximately 26 million people globally in both the developed and developing worlds. Treatment costs, including hospitalizations, are estimated at $108 billion a year worldwide. 

A quick guide to living with heart failure (PDF 1.5 MB)

Before falling ill Mary-Ann had been looking forward to a long, busy retirement and the chance to pursue her favorite pastimes, including skiing, travel and outdoor activities. The diagnosis of heart failure changed all this.

“It was a total, complete, absolute and overwhelming shock,” said Mary-Ann. “I didn’t realize how sick I was until they used that word. You feel like your body’s failed you and you’ll never be the same again.”

The symptoms of heart failure can be debilitating and most patients find they have to drastically slow their pace of life. Even everyday activities like walking and climbing stairs become increasingly difficult.

“I just don’t have the oomph I had,” Mary-Ann said. 

For Michele Packard-Milam, Executive Director of Mended Hearts, a US-based patient organization for people with heart failure, patients experience many fears. Set up in the US more than 60 years ago, Mended Hearts helps people come to terms with their illness and understand there can still be a rich, rewarding life after heart disease diagnosis. 

“Heart failure is one of the most difficult of the chronic heart diseases to manage,” she said. “We visit more than 200,000 patients a year. Many of the patients we visit don’t know they have heart failure or are having difficulty managing heart failure.”

Caring for someone with heart failure (PDF 2 MB)

New approaches to tackling heart failure include efforts by healthcare companies and caregivers to personalize care planning and involve patients more in managing their conditions. New implantable devices can help regulate the heart rate or check patients’ blood pressure, giving physicians early warning of a worsening condition. Drug development efforts seek to find new, more effective ways of using the body’s own systems to control the chronic condition and ultimately better patient outcomes after an episode of acute heart failure. 

Packard-Milam is enthusiastic about the potential impact of these new treatment options. 

“We’re really hopeful that new medications, combined with hard work on the part of the healthcare providers, caregivers and the patients themselves, will yield better quality of life and better longevity for people struggling with heart failure.” 

Tags: 
Chronic Illness, Heart Failure
    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

A woman, accompanied by her caregiver, shares her experiences with a doctor.
Patient Perspectives

Turning the sound up on patient voices in lung cancer research and development

Chinese family embracing exercise and the outdoors
Patient Perspectives

AI Nurse evolving for health failure patients in China

Patient living with chronic myeloid leukemia advocates for herself
Patient Perspectives

Speaking Up in CML

You are here

  1. Home ›
  2. Stories ›
  3. Patient Perspectives

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.